Medicine
Review Cycle Records
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
Paper Review Records
All Paper Review Records
24 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Epitranscriptomic Regulation of PIK3R2 by WTAP/YTHDF3 Axis Drives Nasopharyngeal Carcinoma Progression
Yilong Xu; Yanyu Xu; Yongqin Chen; Shaorong Lin; Yaxue Liu; Sihai Dai; Mingyan HongShow moreShow less
1. Department of Otorhinolaryngology Quanzhou Maternity and Children's Hospital Quanzhou City Fujian Province China; 2. Department of Otolaryngology‐Head and Neck Surgery Quanzhou Maternity and Children's Hospital Quanzhou City Fujian Province ChinaShow moreShow less
Context‐Dependent Associations of GCN1 With Malignant Phenotypes, Immune‐Related Features and Prognosis in Colorectal Cancer
Xinxing Li; Xin Yang; Lin Zhu; Junyong Weng; Zezhi Shan; Zhiqian Hu; Ariela Samantha; Io Nam Wong; Xinxiang LiShow moreShow less
1. Department of Colorectal Surgery Fudan University Shanghai Cancer Center Shanghai China; 2. Department of Oncology, Shanghai Medical College Fudan University Shanghai China; 3. Department of General Surgery, Tongji Hospital, School of Medicine Tongji University Shanghai China; 4. Department of Molecular Diagnostics and Experimental Therapeutics Beckman Research Institute of City of Hope, Biomedical Research Center Monrovia California USA; 5. Proteomics Division, Mochtar Riady Institute for Nanotechnology Universitas Pelita Harapan Tangerang Banten Indonesia; 6. Department of Biology Universitas Pelita Harapan Tangerang Banten Indonesia; 7. Faculty of Medicine, Macau University of Science and Technology Macau China; 8. AI Cross Disciplinary Research Institute, Macau University of Science and Technology Macau China; 9. Dr. Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Mechanism and Quality of Chinese Medicine Macau University of Science and Technology Macau China; 10. Zhuhai MUST Science and Technology Research Institute/Macau University of Science and Technology Innovation Technology Research Institute Hengqin ChinaShow moreShow less
Glucomannan From Acrocomia corumbaensis (Bocaiuva) Attenuates Pain and Inflammation in DSS ‐Induced Colitis via Mucus Barrier Protection
Marcela S. C. Brito; Anderson K. Taporosky; Katlin S. Rech; Lucas B. S. Santos; Marcelo B. Gois; Larissa F. N. de Souza; Rilton A. de Freitas; Carolina A. B. Azevedo; Carolina Mathias; Lucimara M. C. Cordeiro; Maria F. P. WernerShow moreShow less
1. Pharmacology Department Federal University of Paraná Curitiba Paraná Brazil; 2. Biochemistry and Molecular Biology Department Federal University of Paraná Curitiba Paraná Brazil; 3. Faculty of Health Sciences of the Federal University of Rondonópolis Rondonópolis Mato Grosso Brazil; 4. BioPol, Pharmacy Department Federal University of Paraná Curitiba Paraná Brazil; 5. Genetic Department Federal University of Paraná Curitiba Paraná BrazilShow moreShow less
KRIT1 Inhibits TGF ‐β/Smad‐Mediated Endothelial‐To‐Mesenchymal Transition in Pulmonary Arterial Hypertension
Debin Ma; Liang Shi; Congcong Li; Di Song; Lei LiuShow moreShow less
1. Department of Respiratory and Critical Care Medicine General Hospital of Northern Theater Command Shenyang ChinaShow moreShow less
Targeting RAB27A Enhances Pembrolizumab Sensitivity and Alleviates Immune Escape via Inactivation of the PI3K /Akt/ mTOR Pathway in Triple‐Negative Breast Cancer
Tong Sha; Jingjing Fan; Xiaoli Wang; Binlin MaShow moreShow less
1. Department of Breast Thyroid Surgery, Xinjiang Medical University Affiliated Tumor Hospital The Clinical Medical Research Center of Breast and Thyroid Tumors in Xinjiang Urumqi ChinaShow moreShow less
Mechanistic Study of SRSF1 ‐Mediated Inhibition of Treg Cell Function via the mTORC1 / ULK1 Signalling Axis Through Mitophagy in Asthma
Chunhua Ye; Yifu Chen; Qinjun Yi; Zhu Ming; Tuoyu Gan; Rong XiangShow moreShow less
1. Department of Emergency Changsha Hospital for Maternal & Child Health Care Changsha Hunan China; 2. Department of Urology The Affiliated Children's Hospital of Xiangya School of Medicine, Central South University(Hunan Children's Hospital) Changsha Hunan China; 3. Department of Pediatrics Changsha Hospital for Maternal & Child Health Care Changsha Hunan ChinaShow moreShow less
FAQ
How long does CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY take to review a manuscript?
As of 2026-11-17, CrushSCI has 24 complete review records for CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY. The fastest paper went from submission to acceptance in 62 days (18 β‐Glycyrrhetinic Acid Inhibits Malignant Progression of Prostate Cancer via Regulation of Autophagy and EMT Induced by PTEN / PI3K / mTOR Pathway, received 2026-07-01, accepted 2026-09-01); the slowest took 575 days. The average is 165.3 days and the median is 109.5 days.
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.